DE60207913D1 - Als Matrix-Metalloproteinasehemmer verwendbare tricyclische Sulfonamide - Google Patents

Als Matrix-Metalloproteinasehemmer verwendbare tricyclische Sulfonamide

Info

Publication number
DE60207913D1
DE60207913D1 DE60207913T DE60207913T DE60207913D1 DE 60207913 D1 DE60207913 D1 DE 60207913D1 DE 60207913 T DE60207913 T DE 60207913T DE 60207913 T DE60207913 T DE 60207913T DE 60207913 D1 DE60207913 D1 DE 60207913D1
Authority
DE
Germany
Prior art keywords
matrix metalloproteinase
metalloproteinase inhibitors
alkyl
tricyclic
sulfonamides useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60207913T
Other languages
English (en)
Inventor
Patrick Michael O'brien
William Chester Patt
Joseph Armand Picard
Kevon Ray Shuler
Drago Robert Sliskovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of DE60207913D1 publication Critical patent/DE60207913D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE60207913T 2001-02-14 2002-02-08 Als Matrix-Metalloproteinasehemmer verwendbare tricyclische Sulfonamide Expired - Lifetime DE60207913D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26873701P 2001-02-14 2001-02-14

Publications (1)

Publication Number Publication Date
DE60207913D1 true DE60207913D1 (de) 2006-01-19

Family

ID=23024247

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60207913T Expired - Lifetime DE60207913D1 (de) 2001-02-14 2002-02-08 Als Matrix-Metalloproteinasehemmer verwendbare tricyclische Sulfonamide

Country Status (8)

Country Link
US (1) US6559142B2 (de)
EP (1) EP1233017B1 (de)
JP (1) JP2002308859A (de)
AT (1) ATE312829T1 (de)
BR (1) BR0200414A (de)
CA (1) CA2371481A1 (de)
DE (1) DE60207913D1 (de)
MX (1) MXPA01013172A (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
ES2537514T3 (es) 2003-04-04 2015-06-09 Incyte Corporation Composiciones, métodos y kits relacionados con la escisión de HER-2
EP2074107A2 (de) * 2006-10-27 2009-07-01 Wyeth a Corporation of the State of Delaware Trizyklische verbindungen als matrix-metalloprotease-hemmer
DK2099442T3 (en) * 2006-12-26 2015-02-16 Pharmacyclics Inc Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy
CL2008001257A1 (es) * 2007-05-04 2008-07-04 Wyeth Corp Compuestos triciclicos, inhibidores de metaloproteinasas matriciales; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como artritis reumatoide, osteoartritis, aterosclerosis, cancer de pulmon, entre otras.
US9492423B2 (en) 2011-09-13 2016-11-15 Pharmacyclics Llc Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1131215C (zh) 1995-11-13 2003-12-17 赫彻斯特股份公司 环和杂环N－取代的α－亚氨基异羟肟酸和羧酸
AU735013B2 (en) * 1996-09-04 2001-06-28 Warner-Lambert Company Matrix metalloproteinase inhibitors and their therapeutic uses
US6008243A (en) 1996-10-24 1999-12-28 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
IL128545A0 (en) 1996-12-09 2000-01-31 Warner Lambert Co Method for treating and preventing heart failure and ventricular dilatation
AU722784B2 (en) 1997-02-11 2000-08-10 Pfizer Inc. Arylsulfonyl hydroxamic acid derivatives
US6934639B1 (en) 2000-02-25 2005-08-23 Wyeth Methods for designing agents that interact with MMP-13

Also Published As

Publication number Publication date
ATE312829T1 (de) 2005-12-15
EP1233017A1 (de) 2002-08-21
US20020169160A1 (en) 2002-11-14
EP1233017B1 (de) 2005-12-14
BR0200414A (pt) 2003-04-29
JP2002308859A (ja) 2002-10-23
US6559142B2 (en) 2003-05-06
MXPA01013172A (es) 2002-08-21
CA2371481A1 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
MA27567A1 (fr) Perindopril
NO20040100L (no) Nye forbindelser som anti-inflammasjons, immunmodulerende og anti-proliferative midler
ATE526319T1 (de) Aktivator für den peroxisome proliferator- responsiven rezeptor delta
DK1485359T3 (da) Natriumkanalblokkere
BR0207865A (pt) Benzotiadiazinas inibidores de metaloproteinases de matriz
NO994482L (no) Visse cykliske tiosubstituerte acylaminosyreamidderivater
ATE198739T1 (de) 2,3-diaminopropionsäurederivate
ATE452889T1 (de) Die hiv-protease inhibierende sulfonamide
KR960007592A (ko) 신규한 피롤로카바졸
DE60130766D1 (de) Serotoninwiederaufnahme-inhibitoren
DE60207913D1 (de) Als Matrix-Metalloproteinasehemmer verwendbare tricyclische Sulfonamide
ATE502005T1 (de) Amphotere lipidverbindung und deren verwendung
ATE380172T1 (de) Benzylaminanalogen
EA200400806A1 (ru) Способ получения эхинокандиновых соединений
BRPI0416678A (pt) pirazolpirimidinas
ATE291015T1 (de) Alkylaminoderivate
EA200400666A3 (ru) Новые соединения бензотиазина и бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат
DK0819687T3 (da) Benzothiophenforbindelser og anvendelser og formuleringer deraf
DE60221250D1 (de) Bis(5-aryl-2-pyridyl)derivate
DK1312608T3 (da) Discodermolid-analoge samt deres farmaceutiske anvendelse
TW200508211A (en) 2-naphthylimino-1,3-thiazine derivatives
EA200200462A1 (ru) Производные 2-арилхинолина, их получение и терапевтическое применение

Legal Events

Date Code Title Description
8332 No legal effect for de